| Application no. and date | 19203410.6 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 3617330, 20231227 | | Publication date | 20200304 | | Priority no. and date | US 201161471036 P, 20110401 | | EP pub. no. and date |
EP 3617330 20200304 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco, California 94061, US | | Applicant ref. no. | | | Inventor | LIN, Kui, 1 DNA Way
South San Francisco, CA California 94080-4990, US,
PUNNOOSE, Elizabeth, 1 DNA Way
South San Francisco, CA California 94080-4990, US,
SESHAGIRI, Somasekar, 1 DNA Way
South San Francisco, CA California 94080-4990, US | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/58 (2006.01) , C12Q 1/6886 (2018.01) | | Title | BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
